These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23297005)

  • 21. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
    Peyrin-Biroulet L; Chamaillard M
    J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Schäffler H; Rohde M; Rohde S; Huth A; Gittel N; Hollborn H; Koczan D; Glass Ä; Lamprecht G; Jaster R
    World J Gastroenterol; 2018 Mar; 24(11):1196-1205. PubMed ID: 29568200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [NOD2 gene mutation in Moroccan patients with Crohn's disease: prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn's disease].
    Tamzaourte M; Errabih I; Krami H; Maha F; Maria L; Benzzoubeir N; Ouazzani L; Sefiani A; Ouazzani H
    Pan Afr Med J; 2017; 27():116. PubMed ID: 28819537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysbiotic gut microbiome: A key element of Crohn's disease.
    Øyri SF; Műzes G; Sipos F
    Comp Immunol Microbiol Infect Dis; 2015 Dec; 43():36-49. PubMed ID: 26616659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOD2 and bacterial recognition as therapeutic targets for Crohn's disease.
    de Bruyn M; Vermeire S
    Expert Opin Ther Targets; 2017 Dec; 21(12):1123-1139. PubMed ID: 29096557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal intestinal permeability in Crohn's disease pathogenesis.
    Teshima CW; Dieleman LA; Meddings JB
    Ann N Y Acad Sci; 2012 Jul; 1258():159-65. PubMed ID: 22731729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional consequences of NOD2 (CARD15) mutations.
    Abraham C; Cho JH
    Inflamm Bowel Dis; 2006 Jul; 12(7):641-50. PubMed ID: 16804402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Crohn's disease: genetic aspects].
    Loranskaia ID; Stepanova EV
    Ter Arkh; 2010; 82(2):66-70. PubMed ID: 20387682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal permeability in families with Crohn's disease.
    J Med Genet; 2006 Dec; 43(12):923. PubMed ID: 17142621
    [No Abstract]   [Full Text] [Related]  

  • 32. Crohn's disease susceptibility gene interactions, a NOD to the newcomer ATG16L1.
    Cadwell K
    Gastroenterology; 2010 Nov; 139(5):1448-50. PubMed ID: 20875485
    [No Abstract]   [Full Text] [Related]  

  • 33. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
    Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
    Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are NOD2 polymorphisms linked to a specific disease endophenotype of Crohn's disease?
    Jensen SR; Nielsen OH; Brix S
    Inflamm Bowel Dis; 2011 Nov; 17(11):2392-401. PubMed ID: 21337670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacteria in Crohn's disease: a persistent hypothesis.
    Behr MA; Schurr E
    Inflamm Bowel Dis; 2006 Oct; 12(10):1000-4. PubMed ID: 17012971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn's disease.
    Hruz P; Eckmann L
    Swiss Med Wkly; 2010; 140():w13135. PubMed ID: 21213148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Crohn's disease-associated NOD2 variants with intestinal failure requiring small bowel transplantation and clinical outcomes.
    Janse M; Weersma RK; Sudan DL; Festen EA; Wijmenga C; Dijkstra G; Mercer D
    Gut; 2011 Jun; 60(6):877-8; author reply 878-9. PubMed ID: 20940282
    [No Abstract]   [Full Text] [Related]  

  • 38. [Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn's disease].
    Lapis K
    Orv Hetil; 2010 Oct; 151(40):1645-55. PubMed ID: 20860961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.
    Naftali T; Reshef L; Kovacs A; Porat R; Amir I; Konikoff FM; Gophna U
    Inflamm Bowel Dis; 2016 Feb; 22(2):293-302. PubMed ID: 26752462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn's Disease Patients.
    Choteau L; Vasseur F; Lepretre F; Figeac M; Gower-Rousseau C; Dubuquoy L; Poulain D; Colombel JF; Sendid B; Jawhara S
    Sci Rep; 2016 Jul; 6():29636. PubMed ID: 27404661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.